A Randomized, Double-Blind, Placebo-Controlled Trial Investigating The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery (The POPular CABG Study)

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Trial Investigating The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery (The POPular CABG Study)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 May 2017

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Vascular graft occlusion
  • Focus Therapeutic Use
  • Acronyms POPular CABG
  • Most Recent Events

    • 28 Apr 2017 Planned End Date changed from 1 Jul 2018 to 1 Sep 2019.
    • 28 Apr 2017 Planned primary completion date changed from 1 May 2018 to 1 Jul 2019.
    • 13 Apr 2016 Planned End Date changed from 1 Mar 2018 to 1 Jul 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top